Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,199.43 -30.50 (-2.48%)

Official Closing Price Updated: 4:10 PM EDT, Jun 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Why Illumina (ILMN) Stock Is Down Today

Today 14:55 EDT

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation ge...

Via StockStory

Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness ↗

Today 10:17 EDT

FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80 applications.

Via Benzinga

3 Magnificent Dividend ETFs That Could Supercharge Your Passive Income ↗

Today 5:50 EDT

All three ETFs complement each other well in a portfolio.

Via The Motley Fool

Topics ETFs Stocks

Eli Lilly & Co (NYSE:LLY) Screens as a Top Growth Stock with a Strong Technical Breakout Setup ↗

June 25, 2026

Via Chartmill

Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow ↗

Today 5:26 EDT

Among Nvidia, Apple, Alphabet, Microsoft, Amazon, Taiwan Semi, SpaceX, Broadcom, Tesla, Meta, Micron, Eli Lilly, and Berkshire Hathaway, there are a handful of bargains and pretenders.

Via The Motley Fool

Topics Artificial Intelligence Stocks

5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX ↗

Today 4:22 EDT

SpaceX recently completed a record IPO.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering

Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years ↗

Today 3:20 EDT

The weight loss tailwind isn't about to come to a halt.

Via The Motley Fool

Big Pharma Has a Case of Merger Mania ↗

Today 0:46 EDT

Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and clinical-stage candidates to bolster the development pipeline.

Via The Motley Fool

Topics Intellectual Property

5 Places Investors Can Hide If the AI Trade Keeps Cracking ↗

June 29, 2026

As AI stocks face volatility, capital is rotating into biotech, industrials, utilities, consumer staples, and dividend ETFs showing relative strength.

Via MarketBeat

Topics Artificial Intelligence ETFs

3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More ↗

June 29, 2026

Why settle for puny yields when you can buy these monster dividend stocks?

Via The Motley Fool

Topics ETFs Energy

2 Top Growth Stocks to Buy Right Now Without Hesitation ↗

June 29, 2026

These stocks are no-brainer buys.

Via The Motley Fool

Topics Economy

Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗

June 29, 2026

These stocks are better bets to skyrocket than the much-hyped rocket stock.

Via The Motley Fool

Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now ↗

June 27, 2026

Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors.

Via The Motley Fool

Topics Intellectual Property

Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates ↗

June 27, 2026

The top stocks are showing relative strength. Two are defensive growth plays.

Via Investor's Business Daily

Revealed! 3 Undervalued Stocks I Just Bought ↗

June 26, 2026

There are still great opportunities in an otherwise volatile market.

Via The Motley Fool

Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy? ↗

June 26, 2026

Eli Lilly holds a dominant market share in the weight loss treatment category.

Via The Motley Fool

Why Eli Lilly Stock Jumped to a New All-Time High Today ↗

June 26, 2026

The pharma titan is expanding into new markets.

Via The Motley Fool

Lilly Hits Record High Amid Massive Profit Growth, Leads 28 Just Added To Best Stock Lists ↗

June 26, 2026

Eli Lilly is a leader in the revolutionary GLP weight-loss market. Lilly was one of 28 stocks new to best stock lists Friday.

Via Investor's Business Daily

Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly? ↗

June 26, 2026

Novo Nordisk offers dividend income and MASH upside versus Lilly's high‑growth obesity lead.

Via The Motley Fool

Discover which S&P500 stocks are making waves on Friday. ↗

June 26, 2026

Via Chartmill

Why Is Eli Lilly (LLY) Stock Soaring Today

June 26, 2026

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 6.3% in the afternoon session after the European Medicines Agency's commit...

Via StockStory

Snap’s Specs Gamble ↗

June 26, 2026

The smartphone could be a thing of the past if Snap has its way. But at $2,195, it could be a tall order to sell Specs to consumers, even if they were stylish.

Via The Motley Fool

Topics Workforce

Friday's session: top gainers and losers in the S&P500 index ↗

June 26, 2026

Via Chartmill

Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value? ↗

June 26, 2026

Compare global reach to domestic focus as these two funds reveal key differences in cost, risk, and portfolio makeup for healthcare investors.

Via The Motley Fool

Topics ETFs

2 Beaten-Down Artificial Intelligence (AI) Stocks for Contrarian Investors to Consider Buying ↗

June 26, 2026

These aren't for the faint of heart.

Via The Motley Fool

Topics Artificial Intelligence

An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right? ↗

June 25, 2026

Novo Nordisk is no longer the front-runner, but it's not out of the running, either.

Via The Motley Fool

Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial Success ↗

June 25, 2026

ProQR reported positive AX-0810 Phase 1 data and raised $50 million, with Eli Lilly joining a concurrent share purchase.

Via Benzinga

Nancy Pelosi Stock Tracker Flags Eli Lilly, Nokia After Trump Praise: ‘Keep An Eye On These Two’ ↗

June 25, 2026

Nancy Pelosi Stock Tracker told investors to "keep an eye" on Eli Lilly and Nokia after Trump praised the companies in Pennsylvania.

Via Benzinga

Topics Government

The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch ↗

June 25, 2026

These companies' innovative qualities could help them get ahead of their peers in capitalizing on AI.

Via The Motley Fool

Topics Artificial Intelligence

Why Illumina (ILMN) Stock Is Trading Up Today

June 24, 2026

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to ...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Eli Lilly (NY:LLY)

Headline News about Eli Lilly

Starting at $3.75/week.

Subscribe Today